These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31104904)

  • 1. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
    Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
    Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    van Niekerk CC; van Dijck JAAM; Verbeek ALM
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between uterine serous carcinoma and breast cancer.
    Gehrig PA; Bae-Jump VL; Boggess JF; Groben PA; Fowler WC; Van Le L
    Gynecol Oncol; 2004 Jul; 94(1):208-11. PubMed ID: 15262144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical outcomes of non-endometrioid carcinoma of endometrium: Siriraj Hospital experience.
    Jaishuen A; Kunakornporamat K; Viriyapak B; Benjapibal M; Chaopotong P; Petsuksiri J; Therasakvichya S
    Asian Pac J Cancer Prev; 2014; 15(6):2905-9. PubMed ID: 24761923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of WT1, B-cell lymphoma 2, Ki-67 (Mib1), and Her2/Neu as diagnostic and prognostic immunomarkers in ovarian serous and endometroid carcinoma.
    Mondal SK; Basak B; Bhattacharya S; Panda UK
    J Cancer Res Ther; 2021; 17(1):164-169. PubMed ID: 33723149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
    Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
    Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and age at diagnosis of endometrial cancer.
    Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Levitt J; Girda E; Goldfinger M; Goldberg GL; Einstein MH
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):300-306. PubMed ID: 25004350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
    Lee AW; Ness RB; Roman LD; Terry KL; Schildkraut JM; Chang-Claude J; Doherty JA; Menon U; Cramer DW; Gayther SA; Risch H; Gentry-Maharaj A; Goodman MT; Modugno F; Eilber U; Moysich KB; Berchuck A; Rossing MA; Jensen A; Wicklund KG; Cushing-Haugen KL; Hogdall E; Rudolph A; Thompson PJ; Wilkens LR; Kjaer SK; Carney ME; Stram DO; Ramus SJ; Wu AH; Pike MC; Pearce CL;
    Obstet Gynecol; 2016 May; 127(5):828-836. PubMed ID: 27054934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.
    Prentice RL; Thomson CA; Caan B; Hubbell FA; Anderson GL; Beresford SA; Pettinger M; Lane DS; Lessin L; Yasmeen S; Singh B; Khandekar J; Shikany JM; Satterfield S; Chlebowski RT
    J Natl Cancer Inst; 2007 Oct; 99(20):1534-43. PubMed ID: 17925539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
    Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
    Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma.
    Kamal M; Burmeister C; Zhang Z; Munkarah A; Elshaikh MA
    Anticancer Res; 2015 Jul; 35(7):4053-7. PubMed ID: 26124354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
    Hemminki K; Aaltonen L; Li X
    Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial ovarian cancers and endometriosis.
    Acién P; Velasco I; Acién M; Capello C; Vela P
    Gynecol Obstet Invest; 2015; 79(2):126-35. PubMed ID: 25634648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
    Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
    Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.